Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains.

MLA

Weilbeer, Claudia, et al. “Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains.” Frontiers in Oncology, vol. 12, Mar. 2022, p. 819172. EBSCOhost, https://doi.org/10.3389/fonc.2022.819172.

APA

Weilbeer, C., Jay, D., Donnelly, J. C., Gentile, F., Karimi-Busheri, F., Yang, X., Mani, R. S., Yu, Y., Elmenoufy, A. H., Barakat, K. H., Tuszynski, J. A., Weinfeld, M., & West, F. G. (2022). Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains. Frontiers in Oncology, 12, 819172. https://doi.org/10.3389/fonc.2022.819172

Chicago

Weilbeer, Claudia, David Jay, James C Donnelly, Francesco Gentile, Feridoun Karimi-Busheri, Xiaoyan Yang, Rajam S Mani, et al. 2022. “Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains.” Frontiers in Oncology 12 (March): 819172. doi:10.3389/fonc.2022.819172.